Physician profile
Frank J King
NPI 1447218052
$13,187.57
in general payments reported to CMS, 2019-2025
51 companies · $2,343 in 2025
The $2,343 reported for 2025 was more than what 94% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,666 · 2020: $1,101 · 2021: $1,242 · 2022: $1,210 · 2023: $2,809 · 2024: $2,816 · 2025: $2,343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,901 · Education: $67.32.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,901.03 |
| Education | $67.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,285.52 | 2021-2025 | |
| Boston Scientific Corporation | $1,734.72 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $1,145.51 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Accuguide |
| Curonix LLC | $903.51 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Collegium Pharmaceutical, INC. | $749.41 | 2019-2025 | Belbuca, Xtampza |
| Nevro Corp. | $639.35 | 2019-2024 | Senza |
| Abbott Laboratories | $631.62 | 2019-2024 | Proclaim |
| Tersera Therapeutics LLC | $458.52 | 2019-2025 | Prialt |
| Merz Pharmaceuticals, LLC | $419.29 | 2021-2025 | Xeomin |
| Allergan, INC. | $365.60 | 2019-2022 | |
| Almatica Pharma LLC | $333.08 | 2021-2023 | Gralise |
| Medtronic USA, INC. | $298.29 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $231.21 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $200.70 | 2024-2025 | Dysport |
| Valinor Pharma, LLC | $199.92 | 2023-2025 | Movantik |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.